Skip to search formSkip to main contentSkip to account menu

Trileptal

Known as: Novartis brand of oxcarbazepine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
[reaction: see text] A new route to oxcarbazepine (Trileptal), the most widely prescribed antiepileptic drug, starting from… 
Review
2004
Review
2004
Abstract:  Older generation antiepileptic drugs like Phenobarbital (Luminal), carbamazepine (Tegretol), phenytoin (Dilantin), and… 
Highly Cited
2001
Highly Cited
2001
Objective: To evaluate the efficacy and safety of oxcarbazepine (OXC) as monotherapy for patients with uncontrolled partial… 
Review
2001
Review
2001
In an editorial , Marson and Chadwick review some of the evidence for the effectivity and tolerability of new drug treatments for… 
2000
2000
ZusammenfassungOxcarbazepin (10,11-dihydro-10-oxo-5H-dibenz-[b,f]azepin-5-carboxamid; OXC, Handelsname Trileptal®) ist ein neues… 
Highly Cited
1994
Highly Cited
1994
Summary: Oxcarbazepine (OCBZ, Trileptal) and its main human monohydroxy metabolite (MHD) protected mice and rats against… 
1990
1990
  • P. Jensen
  • Behavioural neurology
  • 1990
  • Corpus ID: 44999411
The anti-epileptic activity of oxcarbazepine (OXC) was compared with that of carbamazepine (CBZ) and the primary active…